Loading...
| Name | Option type | Quality (1-5)↓ | Topics | Created | |
|---|---|---|---|---|---|
Will FDA approve Eftilagimod Alpha and Pembrolizumab for PD-L1-negative HNSCC by December 31, 2024?  | Binary | 4 | 5 months ago | ||
Will Immutep's stock price increase by 50% or more by December 31, 2024? | Binary | 3 | 5 months ago | ||
Will the study results be published in a top-tier oncology journal by December 31, 2024? | Binary | 2 | 5 months ago | ||
What will Immutep's stock price be at the end of 2024? | Categorical | 2 | 5 months ago | ||
What will be the market share of Eftilagimod Alpha and Pembrolizumab in first-line treatment of PD-L1-negative HNSCC by December 31, 2024? | Categorical | 2 | 5 months ago | ||
How many new clinical trials for Eftilagimod Alpha will be initiated in 2024? | Categorical | 2 | 5 months ago |